Future Demand and Leading Companies Shaping the Tyrosine Kinase Inhibitors Market to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Tyrosine Kinase Inhibitors Market Heading Into 2029?
The market size for mineral supplements has seen solid expansion over recent years. The market size is projected to increase from $16.58 billion in 2024 to $17.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. Factors contributing to the growth during the historic period include enhanced understanding of health and wellness, a heightened incidence of mineral deficiencies, an older population, an increased emphasis on preventive healthcare along with shifts in diet patterns and lifestyles.
Strong expansion is anticipated in the mineral supplements market size in the coming years, with its valuation expected to reach “$23.06 billion by 2029, registering a compound annual growth rate (CAGR) of 6.8%.” Factors contributing to the market’s growth during the projected period include personalized nutrition trends, heightened demand for organic and natural products among consumers, a rise in disposable incomes in emerging markets, focus on product traceability and transparent labeling, as well as increased consumer concern for sustainability and ethical sourcing. The forecast period will witness key trends such as an uptick in plant-derived mineral supplements, the introduction of targeted mineral formulations catering to specific demographic groups, the incorporation of novel delivery methods like gummies and dissolvable tablets, the expansion of custom mineral supplement solutions for individual needs, and a growing emphasis on evidence-supported ingredients and scientific study.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15609&type=smp
Which Factors Are Pushing The Tyrosine Kinase Inhibitors Market Forward?
The escalating rates of cancer are anticipated to stimulate the expansion of the tyrosine kinase inhibitors market in the forthcoming period. Cancer embodies a wide spectrum of diseases commencing in any organ or tissue within the body where irregular cells uncontrollably multiply, trespass their typical boundaries to infiltrate the adjacent body parts and disseminate to other organs. Tyrosine kinase inhibitors are employed in targeted therapy to aim and eradicate specific cancer cell varieties by obstructing tyrosine kinases that help in curtailing the proliferation of cancer cells. For example, in January 2023, the American Cancer Society, a nonprofit cancer advocacy organization based in the US, reported an increase in the number of cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, an augmentation of 3.16%. Consequently, the rising prevalence of cancer is fuelling the growth of the tyrosine kinase inhibitors market.
The mineral supplements market covered in this report is segmented –
1) By Product: Calcium, Magnesium, Iron, Potassium, Zinc, Chromium, Selenium, Other Products
2) By Formulation: Capsule, Tablet, Powder, Liquid Or Gel, Other Formulations
3) By Sales Channel: Pharmacies And Drug Stores, Supermarkets And Hypermarkets, Online Channels
4) By Application: General Health, Bone And Joint Health, Gastrointestinal Health, Immunity, Other Applications
5) By End Use: Adults, Geriatric, Pregnant Women, Children, Infants
Subsegments:
1) By Calcium: Calcium Carbonate, Calcium Citrate, Calcium Gluconate, Calcium Lactate
2) By Magnesium: Magnesium Citrate, Magnesium Oxide, Magnesium Glycinate, Magnesium Sulfate
3) By Iron: Ferrous Sulfate, Ferrous Fumarate, Ferrous Gluconate, Iron Polysaccharide Complex
4) By Potassium: Potassium Chloride, Potassium Citrate, Potassium Gluconate
5) By Zinc: Zinc Gluconate, Zinc Sulfate, Zinc Picolinate, Zinc Acetate
6) By Chromium: Chromium Picolinate, Chromium Chloride, Chromium Nicotinate
7) By Selenium: Selenium Methionine, Sodium Selenite, Selenomethionine
8) By Other Products: Manganese Supplements, Copper Supplements, Iodine Supplements, Phosphorus Supplements
What Are The Leading Trends And Opportunities In The Tyrosine Kinase Inhibitors Sector?
Companies within the mineral supplement industry are concentrating their efforts on the creation of innovative oral nutrition supplements (ONS) to satisfy the changing needs and tastes of consumers. These oral liquid supplements are often used to fill nutritional gaps and provide extra caloric intake for those who are unable to meet their dietary needs. Arla Foods Ingredients, a Denmark-based supplier specializing in ingredients for infant nutrition, medical applications, and sports nutrition, unveiled its juice-style oral nutritional supplements (ONS) in May 2023. This unique product, geared towards medical nutrition, increases protein content by an impressive 7% without compromising taste or texture. Containing Lacprodan BLG-100, a 100% pure beta-lactoglobulin with a superior nutritional profile, the drink is not only fat-free but also features a low viscosity and remains stable throughout the duration of its shelf life. This new ONS juice-styled product, less astringent and with a better texture than traditional ONS juices, successfully improves adherence to medical nutrition guidelines.
Which Organizations Are Driving Progress In The Tyrosine Kinase Inhibitors Industry?
Major companies operating in the mineral supplements market are Cargill Incorporated, Nestlé S.A., Archer Daniels Midland Company, Pfizer Inc., BASF SE, Bayer AG, Sanofi SA, Abbott Laboratories, GlaxoSmithKline PLC, Otsuka Holdings Co. Ltd., DSM (Koninklijke DSM NV), Amway Corp., Glanbia plc., Orkla, Herbalife International of America Inc., GNC Holdings Inc., Kirkland Signature, Nature’s Way Products LLC, Atrium Innovations Inc., Omega Protein Corporation, NOW Health Group Inc., Ricola, Himalaya Wellness Company, Blackmores Limited, Vitabiotics Ltd., MegaFood, Bio Botanica Inc., Pharmavite LLC
https://www.thebusinessresearchcompany.com/report/mineral-supplements-global-market-report
Which Region Is Expected To Experience The Highest Growth In The Tyrosine Kinase Inhibitors Industry?
North America was the largest region in the mineral supplements market in 2024. The regions covered in the mineral supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15609&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
